4-carbazol-9-yl-9-phenyl-N-(9-phenylcarbazol-2-yl)-N-(2-phenylphenyl)carbazol-2-amine
C60H40N4 — CID 154965993
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-carbazol-9-yl-9-phenyl-N-(9-phenylcarbazol-2-yl)-N-(2-phenylphenyl)carbazol-2-amine
4-carbazol-9-yl-9-phenyl-N-(9-phenylcarbazol-2-yl)-N-(2-phenylphenyl)carbazol-2-amine (PubChem CID 154965993) has the molecular formula C60H40N4 and a molecular weight of 817.01 g/mol. Its IUPAC name is 4-carbazol-9-yl-9-phenyl-N-(9-phenylcarbazol-2-yl)-N-(2-phenylphenyl)carbazol-2-amine.
Molecular Properties
| Compound Name | 4-carbazol-9-yl-9-phenyl-N-(9-phenylcarbazol-2-yl)-N-(2-phenylphenyl)carbazol-2-amine |
|---|---|
| PubChem CID | 154965993 |
| Molecular Formula | C60H40N4 |
| Molecular Weight | 817.01 g/mol |
| Exact Mass | 816.33 |
| IUPAC Name | 4-carbazol-9-yl-9-phenyl-N-(9-phenylcarbazol-2-yl)-N-(2-phenylphenyl)carbazol-2-amine |
| SMILES | c1ccc(-c2ccccc2N(c2ccc3c4ccccc4n(-c4ccccc4)c3c2)c2cc(-n3c4ccccc4c4ccccc43)c3c4ccccc4n(-c4ccccc4)c3c2)cc1 |
| InChI | InChI=1S/C60H40N4/c1-4-20-41(21-5-1)46-26-10-15-31-52(46)61(44-36-37-50-49-29-11-16-32-53(49)62(57(50)38-44)42-22-6-2-7-23-42)45-39-58-60(51-30-14-19-35-56(51)63(58)43-24-8-3-9-25-43)59(40-45)64-54-33-17-12-27-47(54)48-28-13-18-34-55(48)64/h1-40H |
| InChIKey | ADVNTTOEPNARTO-UHFFFAOYSA-N |
| XLogP | 16.11 |
| TPSA | 18.03 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 64 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 817.01 |
| LogP ≤ 5 | 16.11 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 154965993 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.